Cyclerion Therapeutics (CYCN) Research & Development (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Research & Development of $348000.0 in Q3 2025, up 521.43% quarter-over-quarter from $56000.0 in Q2 2025, and up 329.63% on a YoY basis from $81000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Research & Development (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Research & Development history runs 8 years deep, the most recent figure standing at $348000.0 for Q3 2025.
- In Q3 2025, Research & Development rose 329.63% year-over-year to $348000.0; the TTM figure through Sep 2025 stood at $496000.0 (up 95.28% YoY), while the FY2024 annual figure was $286000.0, down 81.12% from the prior year.
- Research & Development was $348000.0 for Q3 2025 at Cyclerion Therapeutics, up from $56000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $12.1 million in Q2 2021 to a low of $24000.0 in Q4 2023.
- Historically, Research & Development has averaged $3.3 million across 5 years, with a median of $572000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Research & Development sank 97.96% in 2023, then surged 329.63% in 2025.
- A 5-year view of Research & Development shows it stood at $10.5 million in 2021, then sank by 88.76% to $1.2 million in 2022, then tumbled by 97.96% to $24000.0 in 2023, then jumped by 133.33% to $56000.0 in 2024, then jumped by 521.43% to $348000.0 in 2025.
- The last three Research & Development figures came in at $348000.0 (Q3 2025), $56000.0 (Q2 2025), and $36000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 580,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 572,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 10.22 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 10.46 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 12.05 Mn |
| Mar 31, 2021 | 8.09 Mn |
| Dec 31, 2020 | 12.09 Mn |